M
Mineralys Therapeutics Inc
NASDAQ:MLYS
Mineralys Therapeutics Inc
NASDAQ:MLYS
Price:
27.17
USD
-2.13%
Market Cap:
$2.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Mineralys Therapeutics Inc
NASDAQ:MLYS
|
US |
|
Digilife Technologies Ltd
SGX:BAI
|
SG |
|
Treace Medical Concepts Inc
NASDAQ:TMCI
|
US |
|
A
|
Anhui Wanwei Updated High-tech Material Industry Co Ltd
SSE:600063
|
CN |
|
Toyo Corp
TSE:8151
|
JP |
|
Gjensidige Forsikring ASA
OSE:GJF
|
NO |
|
Sivers Semiconductors AB
STO:SIVE
|
SE |
|
S
|
Spectral AI Inc
NASDAQ:MDAI
|
US |
|
Nippon Indosari Corpindo Tbk PT
IDX:ROTI
|
ID |
|
Live Company Group PLC
LSE:LVCG
|
UK |
|
Morito Co Ltd
TSE:9837
|
JP |
|
E
|
E-Tron Co Ltd
KOSDAQ:096040
|
KR |
|
Astral Ltd
NSE:ASTRAL
|
IN |
|
B
|
Biomimix Inc
OTC:BMMX
|
US |
|
E
|
Euroholdings Ltd
NASDAQ:EHLDV
|
GR |
Wall Street
Price Targets
MLYS Price Targets Summary
Mineralys Therapeutics Inc
Mineralys Therapeutics Inc
Wall Street analysts forecast MLYS stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for MLYS is 50.36 USD with a low forecast of 30.3 USD and a high forecast of 58.8 USD.
Lowest
Price Target
30.3
USD
12% Upside
Average
Price Target
50.36
USD
85% Upside
Highest
Price Target
58.8
USD
116% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MLYS's stock price target?
Price Target
50.36
USD
50.36
USD
According to Wall Street analysts, the average 1-year price target for MLYS is 50.36 USD with a low forecast of 30.3 USD and a high forecast of 58.8 USD.
